메뉴 건너뛰기




Volumn 59, Issue 7, 1998, Pages 539-542

Novel therapeutic approaches to psoriasis

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; DRUG DERIVATIVE; RETINOID;

EID: 0032113444     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (23)
  • 1
    • 33745130668 scopus 로고
    • The pathophysiology of psoriasis
    • Barker JNWN (1991) The pathophysiology of psoriasis. Br J Dermatol 119: 445-61
    • (1991) Br J Dermatol , vol.119 , pp. 445-461
    • Barker, J.N.W.N.1
  • 2
    • 8244228685 scopus 로고    scopus 로고
    • Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study
    • Berth-Jones J, Henderson CA, Munro CS et al (1997) Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study. Br J Dermatol 136: 527-30
    • (1997) Br J Dermatol , vol.136 , pp. 527-530
    • Berth-Jones, J.1    Henderson, C.A.2    Munro, C.S.3
  • 4
    • 0028286895 scopus 로고
    • Treatment of psoriasis by topical photodynamic therapy with polychromatic light
    • Boehncke WH, Sterry W, Haufman R (1994) Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343: 801
    • (1994) Lancet , vol.343 , pp. 801
    • Boehncke, W.H.1    Sterry, W.2    Haufman, R.3
  • 5
    • 0029155801 scopus 로고
    • Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis an open study with oral liarozole
    • Dockx D, Decree J, Degreef H (1995) Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis an open study with oral liarozole. Br J Dermatol 133: 426-32
    • (1995) Br J Dermatol , vol.133 , pp. 426-432
    • Dockx, D.1    Decree, J.2    Degreef, H.3
  • 7
    • 0030002445 scopus 로고    scopus 로고
    • Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo controlled study
    • European FK506 Multicentre Psoriasis Study Group (1996) Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo controlled study. Arch Dermatol 136: 419-23
    • (1996) Arch Dermatol , vol.136 , pp. 419-423
  • 8
    • 0025244112 scopus 로고
    • Validation of sickness impact profile and psoriasis disability index in psoriasis
    • Finlay AY, Khan GK, Lascombe D et al (1990) Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 123: 751-6
    • (1990) Br J Dermatol , vol.123 , pp. 751-756
    • Finlay, A.Y.1    Khan, G.K.2    Lascombe, D.3
  • 9
    • 0023720550 scopus 로고
    • Psoriasis
    • Fry L (1988) Psoriasis. Br J Dermatol 119: 445-61
    • (1988) Br J Dermatol , vol.119 , pp. 445-461
    • Fry, L.1
  • 10
    • 0024261656 scopus 로고
    • 311μm UVB phototherapy - An effective treatment for psoriasis
    • Green C, Ferguson J, Lakshmipath T, Johnson B (1988) 311μm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 199: 691-6
    • (1988) Br J Dermatol , vol.199 , pp. 691-696
    • Green, C.1    Ferguson, J.2    Lakshmipath, T.3    Johnson, B.4
  • 12
    • 0028990380 scopus 로고
    • Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggest a primary immune, but not keratinocyte, pathogenic basis
    • Gottlieb SL, Gilleaudeau P, Johnson R et al (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggest a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1: 442-7
    • (1995) Nature Med , vol.1 , pp. 442-447
    • Gottlieb, S.L.1    Gilleaudeau, P.2    Johnson, R.3
  • 13
    • 33745168582 scopus 로고    scopus 로고
    • Calcipotriene treatment of psoriasis results in an early induction of interleukin-10 and a concomitant reduction in interleukin-8 level
    • Kang S, Choi J-H, Yi S et al (1996) Calcipotriene treatment of psoriasis results in an early induction of interleukin-10 and a concomitant reduction in interleukin-8 level. Br J Dermatol 135(5): 836
    • (1996) Br J Dermatol , vol.135 , Issue.5 , pp. 836
    • Kang, S.1    Choi, J.-H.2    Yi, S.3
  • 15
    • 0024822201 scopus 로고
    • Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC903)
    • Kragballe K (1989) Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC903). Arch Dermatol 125: 1647-52
    • (1989) Arch Dermatol , vol.125 , pp. 1647-1652
    • Kragballe, K.1
  • 16
    • 0029784520 scopus 로고    scopus 로고
    • A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis
    • Lebwohl M, Siskin SB, Epinette W et al (1996) A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 35: 268-9
    • (1996) J Am Acad Dermatol , vol.35 , pp. 268-269
    • Lebwohl, M.1    Siskin, S.B.2    Epinette, W.3
  • 17
    • 0013600514 scopus 로고    scopus 로고
    • CTLA41g (BMS-188667)-mediated blockade of T Cell costimulation in patients with psoriasis vulgaris
    • Lebwohl M, Kang S, Guzzo C et al (1997) CTLA41g (BMS-188667)-mediated blockade of T Cell costimulation in patients with psoriasis vulgaris. J Invest Dermatol 108: 570
    • (1997) J Invest Dermatol , vol.108 , pp. 570
    • Lebwohl, M.1    Kang, S.2    Guzzo, C.3
  • 18
    • 0026588246 scopus 로고
    • Immunosuppressive macrolides of the type FK506: A novel class of topical agents for treatment of skin diseases?
    • Meingassner JG, Stutz A (1992) Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 98: 851-5
    • (1992) J Invest Dermatol , vol.98 , pp. 851-855
    • Meingassner, J.G.1    Stutz, A.2
  • 20
    • 0025735332 scopus 로고
    • Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis?
    • Poizot-Martin I, Dhiver C, Mawas M et al (1991) Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis? Lancet 337: 1477
    • (1991) Lancet , vol.337 , pp. 1477
    • Poizot-Martin, I.1    Dhiver, C.2    Mawas, M.3
  • 21
    • 0030010432 scopus 로고    scopus 로고
    • Clearing of psoriasis by a novel immunosuppressive macrolide
    • Rappersberger K, Meingassner JG, Fialla R et al (1996) Clearing of psoriasis by a novel immunosuppressive macrolide. J Invest Dermatol 106: 701-10
    • (1996) J Invest Dermatol , vol.106 , pp. 701-710
    • Rappersberger, K.1    Meingassner, J.G.2    Fialla, R.3
  • 22
    • 0029857629 scopus 로고    scopus 로고
    • Tacalcitol ointment in the treatment of psoriasis vulgaris: A multicentre, placebo-controlled, double-blind study on efficacy and safety
    • Van de Kerkhof PCM, Haustein UF, Luger T et al (1996) Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 135: 758-65
    • (1996) Br J Dermatol , vol.135 , pp. 758-765
    • Van De Kerkhof, P.C.M.1    Haustein, U.F.2    Luger, T.3
  • 23
    • 0029848032 scopus 로고    scopus 로고
    • A novel dithranol formulation (Micanol): The effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris
    • Van der Vleuten CJ, Gerritsen MJ, De Jong EM et al (1996) A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris. Acta Derm Venereol 76: 387-91
    • (1996) Acta Derm Venereol , vol.76 , pp. 387-391
    • Van Der Vleuten, C.J.1    Gerritsen, M.J.2    De Jong, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.